IRF3 and amyotrophic lateral sclerosis: On the other hand, the ALS-associated mutants of Optn abrogate the inhibitory function of Optn on IRF3 activation in response to MDA5, or TRIF overexpression [37], suggesting a potential effect of these mutants on the TBK1/CYLD inhibitory mechanism.